Skip to search formSkip to main contentSkip to account menu

gadodiamide

Known as: Gd-DTPA-BMA, Gd-DTPA bis-(methylamide), Gadolinium, (5,8-bis((carboxy-kappaO)methyl)-11-(2-(methylamino)-2-(oxo-kappaO)ethyl)-3-(oxo-kappaO)-2,5,8,11-tetraazatridecan-13-oato(3-)-kappaN5,kappaN8,kappaN11,kappaO13)- 
A paramagnetic gadolinium-based contrast agent (GBCA), with imaging activity upon magnetic resonance imaging (MRI). When placed in a magnetic field… 
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2010
2010
Purpose:To compare the intraindividual differences of dynamic signal characteristics for 3 gadolinium chelates (gadopentetate… 
2005
2005
Objectives:The purpose of this study was to evaluate the extent to which various commercially available gadolinium-containing… 
2005
2005
After only two months as commissioner, but 30 years at the organisation, Lester Crawford, head of the Food and Drug… 
2003
2003
The morale sapping erosion of doctors' clinical autonomy will be one of Dr Ian Bogle's lasting memories of his five years as… 
2003
2003
For the pervaporation of water-ethanol mixtures, new composite membranes having poly(acrylic acid)-poly(butyl methacrylate-co… 
2001
2001
Figure S1. Experimental proton T1 relaxation enhancements R1, measured with a 5 mM solution of ubiquitin in the presence of 4 mM… 
Highly Cited
2000
Highly Cited
2000
Gadolinium is used as a relaxation agent in magnetic resonance imaging (MRI) because of its large paramagnetic moment, high water… 
2000
2000
Purpose: To study the incidence of adverse events after i.v. injection of MR contrast agents in a Chinese population. A… 
1992
1992
An experimental rationale is provided to differentiate between the terms ionic and nonionic for magnetic resonance (MR) imaging… 
Review
1989